Medtronic® devices have been widely used off-label during spine fusion surgery, which has been associated with a high rate of serious and potentially fatal complications.
Infuse Bone Graft Update 5/19/14: The number of lawsuits filed against Medtronic Inc. over its Infuse Spinal Fusion Device has grown to 1000, with many more cases expected in the coming weeks and months. In May 2014, Medtronic informed investors that it will pay out $22 million to settle about 950 Infuse Bone Graft Lawsuits, and is setting aside an additional $140 million to settle an anticipated 3,800 more complaints. Click Here to learn more.
Infuse Bone Graft Lawsuit Update 5/6/14: Medtronic Inc. has stated that it will pay out $22 million to settle about 1,000 lawsuits over its Infuse Bone Graft, and is reportedly setting aside an additional $140 million for complaints expected to be filed in the future. The announcement marks the latest chapter in a decade-long saga that’s come to symbolize how conflicts of interest in the medical community can affect patients. Click here to learn more.
Medtronic Infuse Bone Graft Update 9/18/13: A new study has identified a potential link between the Medtronic Infuse Bone Graft and cancer. While researchers have theorized that the graft itself is probably not a carcinogen, the device has been associated with cancer and it may promote the disease. Click here to learn more.
The Medtronic Infuse Bone Graft contains recombinant human Bone Morphogenetic Protein (rhBMP-2), a protein released naturally by the body. According to the company, the device provides a scaffolding where new bone can grow. It is approved to treat a spinal condition called Degenerative Disc Disease, as well as open fractures of the tibia.
Medtronic Infuse Bone Graft FDA Warning
In July 2008, the FDA warned the Infuse Bone Graft had caused serious problems when it was used off-label in cervical spine fusion surgeries. The agency said it received 38 reports over four years of side effects – mainly swelling of neck and throat tissue – which resulted in compression of the airway and other structures in the neck. Patients reported difficulty swallowing, breathing, and speaking. Several required emergency treatment, including tracheotomies and the insertion of feeding tubes, as well as second surgeries.
Most complications occurred between 2 and 14 days post-operatively with only a few events occurring prior to day 2. When airway complications occurred, medical intervention was frequently necessary. Treatments included respiratory support with intubation, anti-inflammatory medication, tracheotomy and most commonly second surgeries to drain the surgical site.
Do I have a Medtronic Spine Fusion Injury Lawsuit?
The Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Medtronic spinal device recall lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.
Free Medtronic Spine Fusion Recall Case Evaluation: If you or a loved one has experienced a Medtronic device failure or breakage and would like to find out if you qualify to seek compensation for the injuries and losses you’ve incurred, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.